In patients with intermediate- to high-risk, use of pegfilgrastim biosimilars could optimize management of FN risk. Use of biosimilar pegfilgrastim as a prophylaxis in patients with cancer and a high ...

New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pegfilgrastim Biosimilars Global Market Report 2023" - https://www ...

Learn everything you need to know about Pegfilgrastim-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

Investigators concluded that reference or biosimilar pegfilgrastim could be safely administered to patients with lymphoma on the same day they receive chemotherapy, which could reduce scheduling ...

Two authors (TK, MK) systematically searched electronic databases PubMed, EMBASE and CENTRAL. Databases were searched using a combination of PubMed MeSH terms and relevant search terms for ‘filgrastim ...

Credit: Coherus. The on-body injector includes features such as a retractable needle mechanism, an indicator, status light and auditory signal to help patients confirm the dose has been administered.

Comparison of the Prognostic Value of Assessing Tumor Diameter Versus Tumor Volume at Diagnosis or in Response to Initial Chemotherapy in Rhabdomyosarcoma Whole-Genome Profiling of Pediatric Diffuse ...

REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS) today announced the launch of UDENYCA ONBODY™, the company's on-body injector (OBI) ...

The use of high-dose myeloablative chemo- and radiotherapy to treat cancer requires transplantation of autologous or allogeneic blood stem cells to ensure complete long-term recovery of haemopoiesis ...

Review the side-effects of Pegfilgrastim as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...